scispace - formally typeset
J

Joan Overhauser

Researcher at Thomas Jefferson University

Publications -  72
Citations -  2946

Joan Overhauser is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Chromosome 18 & Gene. The author has an hindex of 32, co-authored 72 publications receiving 2881 citations. Previous affiliations of Joan Overhauser include University of California, Irvine.

Papers
More filters
Journal ArticleDOI

Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells

TL;DR: Evidence is presented which supports the hypothesis that certain M-MuLV regulatory sequences do not function in EC cells and that viral gene expression is not observed even at early times.
Journal Article

Human Exonuclease I Interacts with the Mismatch Repair Protein hMSH2

TL;DR: In this paper, a human exonuclease (hExoI) was found to interact strongly with the human MMR protein hMSH2, suggesting its involvement in the MMR process and/or DNA recombination.
Journal ArticleDOI

Hemizygosity of δ-Catenin (CTNND2) Is Associated with Severe Mental Retardation in Cri-du-Chat Syndrome

TL;DR: Findings and the properties of δ-catenin as a neuronal-specific protein, expressed early in development and involved in cell motility, support its role in the mental retardation of CDCS when present in only one copy.
Journal ArticleDOI

Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products

TL;DR: Type 5 adenovirus mutants that differentially express E1A 13S, 12S, or 9S mRNAs were constructed to study the role of their gene products in transformation and the plasmid pD1/D2, which directs the synthesis of the 54-AA protein only, was found to transform baby rat kidney cells at low frequency.
Journal ArticleDOI

Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome

TL;DR: The results demonstrate the need for careful characterization of a 5p deletion in prenatal cases before clinical predictions are made and identify several chromosomal regions that were involved in specific clinical features.